2020 CMR International Pharmaceutical R&D Factbook
The Centre for Medicines Research (CMR) International, a wholly owned subsidiary of Clarivate, pioneered the development of reliable approaches to benchmarking pharmaceutical R&D.
The 2020 CMR Pharmaceutical R&D Factbook brings together proprietary data from leading pharma and biotech companies – of all sizes and therapy areas – to provide objective information and actionable insights to power your R&D strategy with trusted expert analysis.
The 2020 CMR Pharmaceutical R&D Factbook brings together proprietary data from leading pharma and biotech companies – of all sizes and therapy areas – to provide objective information and actionable insights to power your R&D strategy with trusted expert analysis.
You need reliable, accurate industry benchmarks to evaluate your R&D programs’ performance and make strategic decisions. Turn to CMR, an independent, yet connected source, to uncover industry trends and benchmarks. 74% of top 50 pharma rely on CMR’s 20+ years of experience to inform their R&D decisions.
Get detailed insights and analysis to benchmark your R&D strategy against your peers:
Global pharmaceutical R&D spend and annual changes for 15 years (2009-2023)
Projected global R&D spend growth rate through 2023
Development time and region of first launch for new molecular entities between 2010-2019
Change in number of lead projects in development for first launch by therapeutic area
Euismod in pellentesque massa placerat duis ultricies lacus sed. Sit amet luctus venenatis lectus magna fringilla urna porttitor rhoncus.
INDISPENSABLE PHARMACEUTICAL BENCHMARKS AND TRENDS